Biodel Inc 4
4 · Biodel Inc · Filed Oct 19, 2009
Insider Transaction Report
Form 4
Biodel IncBIOD
KROIN DAVID
Director
Transactions
- Sale
Common Stock
2009-10-16$5.03/sh−7,000$35,210→ 1,245,100 total - Sale
Common Stock
2009-10-15$5.08/sh−7,600$38,608→ 1,252,100 total
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 19, 2009.
- [F2]This transaction was executed in multiple trades at prices ranging from $5.02 to 5.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $5.00 to 5.09. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]The amount shown represents the beneficial ownership of the issuer's securities by Great Point Partners I, L.P., which may be deemed attributable to Mr. Kroin because Mr. Kroin is a co-founder and managing director of Great Point Partners I, L.P. Mr. Kroin serves as a director of the issuer as a representative of Great Point Partners I, L.P., and accordingly Great Point Partners I, L.P. may be deemed to be a director by deputization. Mr. Kroin disclaims beneficial ownership of the shares except to the extent of his pecuinary interest therein.